BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33964732)

  • 21. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
    Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
    Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ichtyosiform erythroderma revealing a severe combined immunodeficiency].
    Ghariani Fetoui N; Boussofara L; Hmida D; Mokni S; Mekki N; Ben Mustapha I; Belajouza C; Ghariani N; Picard C; Denguezli M
    Ann Dermatol Venereol; 2020 Feb; 147(2):131-134. PubMed ID: 31973905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From Severe Combined Immunodeficiency to Omenn syndrome after hematopoietic stem cell transplantation in a RAG1 deficient family.
    Martinez-Martinez L; Vazquez-Ortiz M; Gonzalez-Santesteban C; Martin-Nalda A; Vicente A; Plaza AM; Badell I; Alsina L; de la Calle-Martin O
    Pediatr Allergy Immunol; 2012 Nov; 23(7):660-6. PubMed ID: 22882342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Necrotizing enterocolitis in an infant with Omenn syndrome.
    Lynch MK; Jones CH; Gaye A; Manteuffel KK
    Allergy Asthma Proc; 2006; 27(6):537-43. PubMed ID: 17176792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.
    Villa A; Sobacchi C; Notarangelo LD; Bozzi F; Abinun M; Abrahamsen TG; Arkwright PD; Baniyash M; Brooks EG; Conley ME; Cortes P; Duse M; Fasth A; Filipovich AM; Infante AJ; Jones A; Mazzolari E; Muller SM; Pasic S; Rechavi G; Sacco MG; Santagata S; Schroeder ML; Seger R; Strina D; Ugazio A; Väliaho J; Vihinen M; Vogler LB; Ochs H; Vezzoni P; Friedrich W; Schwarz K
    Blood; 2001 Jan; 97(1):81-8. PubMed ID: 11133745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings.
    Pasic S; Djuricic S; Ristic G; Slavkovic B
    Acta Paediatr; 2009 Jun; 98(6):1062-4. PubMed ID: 19243569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound heterozygous mutation of Rag1 leading to Omenn syndrome.
    Matthews AG; Briggs CE; Yamanaka K; Small TN; Mooster JL; Bonilla FA; Oettinger MA; Butte MJ
    PLoS One; 2015; 10(4):e0121489. PubMed ID: 25849362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations in the RNA component of RNase mitochondrial RNA processing might cause Omenn syndrome.
    Roifman CM; Gu Y; Cohen A
    J Allergy Clin Immunol; 2006 Apr; 117(4):897-903. PubMed ID: 16630949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
    Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
    J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.
    Tabori U; Mark Z; Amariglio N; Etzioni A; Golan H; Biloray B; Toren A; Rechavi G; Dalal I
    Clin Genet; 2004 Apr; 65(4):322-6. PubMed ID: 15025726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Omenn Syndrome and DNA recombination defects].
    Yachie A
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical Omenn Syndrome Due to RAG2 Gene Mutation, a Case Report.
    Pourvali A; Arshi S; Nabavi M; Bemanian MH; Shokri S; Shahrooei M; Rezaei N; Fallahpour M
    Iran J Immunol; 2019 Dec; 16(4):334-338. PubMed ID: 31885011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A newly found homozygous mutation in recombination activating gene 1 in a patient with leaky severe combined immunodeficiency disorder.
    Salari F; Zaremehrjardi F; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Seif F; Movahedi M; Nabavi M
    Mol Biol Rep; 2019 Dec; 46(6):6571-6575. PubMed ID: 31520268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omenn syndrome does not live by V(D)J recombination alone.
    Marrella V; Maina V; Villa A
    Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):525-31. PubMed ID: 22001740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A variant of RAG1 gene identified in severe combined immunodeficiency: a case report.
    Zhang X; Kang X; Yang M; Cai Z; Song Y; Zhou X; Cao J; Wang C; Huang K; Peng Y; He J; Xiao Z
    BMC Pediatr; 2023 Feb; 23(1):56. PubMed ID: 36732712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
    Lee YN; Frugoni F; Dobbs K; Walter JE; Giliani S; Gennery AR; Al-Herz W; Haddad E; LeDeist F; Bleesing JH; Henderson LA; Pai SY; Nelson RP; El-Ghoneimy DH; El-Feky RA; Reda SM; Hossny E; Soler-Palacin P; Fuleihan RL; Patel NC; Massaad MJ; Geha RS; Puck JM; Palma P; Cancrini C; Chen K; Vihinen M; Alt FW; Notarangelo LD
    J Allergy Clin Immunol; 2014 Apr; 133(4):1099-108. PubMed ID: 24290284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
    Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
    J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial V(D)J recombination activity leads to Omenn syndrome.
    Villa A; Santagata S; Bozzi F; Giliani S; Frattini A; Imberti L; Gatta LB; Ochs HD; Schwarz K; Notarangelo LD; Vezzoni P; Spanopoulou E
    Cell; 1998 May; 93(5):885-96. PubMed ID: 9630231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutation c.256_257delAA in RAG1 Gene in Polish Children with Severe Combined Immunodeficiency: Diversity of Clinical Manifestations.
    Szaflarska A; Rutkowska-Zapała M; Kotula M; Gruca A; Grabowska A; Lenart M; Surman M; Trzyna E; Mordel A; Pituch-Noworolska A; Siedlar M
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):177-183. PubMed ID: 28083621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations in Recombination Activating Gene 1 and 2 in patients with severe combined immunodeficiency disorders in Egypt.
    Meshaal S; El Hawary R; Elsharkawy M; Mousa RK; Farid RJ; Abd Elaziz D; Alkady R; Galal N; Massaad MJ; Boutros J; Elmarsafy A
    Clin Immunol; 2015 Jun; 158(2):167-73. PubMed ID: 25869295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.